Luo Mingzhi, Yu Peili, Ni Kai, Jin Yang, Liu Lei, Li Jingjing, Pan Yan, Deng Linhong
Changzhou Key Laboratory of Respiratory Medical Engineering, Institute of Biomedical Engineering and Health Sciences, Changzhou University.
Key Lab of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University.
Biol Pharm Bull. 2020 Jul 1;43(7):1027-1034. doi: 10.1248/bpb.b19-00825. Epub 2020 May 13.
Excessive contraction of airway smooth muscle cells (ASMCs) is a hallmark feature of asthma. Intriguing, the activation of bitter taste receptor (TAS2R) in ASMCs can relax ASMCs. However, there is a lack of potent TAS2R agonists that can be used in asthma therapies since those tested agonists cannot relax ASMCs at the dose below a few hundred micromolar. Considering that sanguinarine (SA) is a bitter substance often used in small doses for the treatment of asthma in folk medicine, the present study was to determine the rapid relaxation effect of SA on ASMCs and to reveal the underlying mechanisms associated with TAS2R signaling. Here, cell stiffness, traction force, calcium signaling, cAMP levels, and the mRNA expression were evaluated by using optical magnetic twisting cytometry, traction force microscopy, Fluo-4/AM labeling, enzyme-linked immunosorbent assay (ELISA), and quantitative (q)RT-PCR, respectively. We found that 0.5 µM SA immediately decreased cell stiffness and traction force, which is comparable with the effect of 5 µM isoproterenol. In addition, 0.5 µM SA immediately increased intracellular free calcium concentration ([Ca]) and decreased the mRNA expression of contractile proteins such as calponin and α-smooth muscle actin after the treatment for 24 h. Furthermore, SA-mediated decrease in cell stiffness/traction force and increase in [Ca] were significantly blunted by inhibiting the TAS2Rs signaling. These findings establish the rapid relaxation effect of SA at low concentration (<1 µM) on cultured ASMCs depending on TAS2R signaling, indicating that SA might be developed as a useful bronchodilator in asthma therapy.
气道平滑肌细胞(ASMCs)过度收缩是哮喘的一个标志性特征。有趣的是,ASMCs中苦味受体(TAS2R)的激活可使ASMCs舒张。然而,目前缺乏可用于哮喘治疗的强效TAS2R激动剂,因为所测试的激动剂在低于几百微摩尔的剂量下无法使ASMCs舒张。鉴于血根碱(SA)是一种在民间医学中常用于小剂量治疗哮喘的苦味物质,本研究旨在确定SA对ASMCs的快速舒张作用,并揭示与TAS2R信号传导相关的潜在机制。在此,分别使用光磁扭转细胞术、牵引力显微镜、Fluo-4/AM标记、酶联免疫吸附测定(ELISA)和定量(q)RT-PCR评估细胞硬度、牵引力、钙信号、cAMP水平和mRNA表达。我们发现,0.5 μM SA可立即降低细胞硬度和牵引力,这与5 μM异丙肾上腺素的作用相当。此外,0.5 μM SA在处理24小时后可立即增加细胞内游离钙浓度([Ca]),并降低收缩蛋白如钙调蛋白和α-平滑肌肌动蛋白的mRNA表达。此外,通过抑制TAS2R信号传导,SA介导的细胞硬度/牵引力降低和[Ca]增加明显减弱。这些发现证实了低浓度(<1 μM)的SA对培养的ASMCs具有依赖于TAS2R信号传导的快速舒张作用,表明SA可能被开发成为哮喘治疗中一种有用的支气管扩张剂。